Landscapes / Targets
FKBP12
2 drugs act on FKBP12, in 2 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs2
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Calcineurin inhibitor immunosuppressant |
Approved | 31 Dec 2027Phase 1 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Age-Related Macular Degeneration | ||||
| Open drug page | |||||
— |
Phase 3 | 31 May 2028Phase 3 trial completes | |||
| Next date | 31 May 2028 · Phase 3 trial completes | ||||
| Also tested for | Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH) and 3 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 2 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026